◆英語タイトル：Genentech, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4873
◆発行会社（調査会社）：
MarketLine
◆発行日：2020年2月
◆ページ数：55
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Genentech, Inc. – Strategy, SWOT and Corporate Finance Report
Summary
Genentech, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Genentech, Inc. (Genentech) is a biotechnology company. It primarily discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company’s medicines include Activase, Boniva Tablets, Cotellic, Erivedge, Fuzeon, Gazyva, Hemlibra, Invirase, Klonopin, Lucentis, Actemra, Nutropin AQ, Ocrevus, Tamiflu, Pegasys, Rituxan, Rocephin, Tecentriq, Polivy, Rozlytrek, Valium, Xeloda and Zelboraf. The company offers its products with a focus on the areas of oncology, immunology, neuroscience, metabolism, ophthalmology and infectious disease. Genentech manages its manufacturing facilities and distribution center in California and Oregon states of the US. The company is headquartered in South San Francisco, California, the US.
Scope
- Detailed information on Genentech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
- Intelligence on Genentech, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genentech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Genentech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genentech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Genentech, Inc.’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
Genentech, Inc.: Company Overview
Genentech, Inc.: Overview and Key Facts
Genentech, Inc.: Overview
Genentech, Inc.: Key Facts
Genentech, Inc.: Key Employees
Genentech, Inc.: Key Employee Biographies
Genentech, Inc.: Major Products and Services
Genentech, Inc.: Company History
Genentech, Inc.: Locations and Subsidiaries
Genentech, Inc.: Key Competitors
Genentech, Inc.: Company Analysis
Genentech, Inc.: Business Description
Genentech, Inc.: SWOT Analysis
Genentech, Inc.: SWOT Overview
Genentech, Inc.: Strengths
Genentech, Inc.: Weaknesses
Genentech, Inc.: Opportunities
Genentech, Inc.: Threats
Genentech, Inc.: Corporate Financial Deals Activity
Genentech, Inc.: Financial Deals Overview
Genentech, Inc.: Targets and Partners
Genentech, Inc.: Top Deals 2016 – 2020YTD*
Genentech, Inc.: Mergers and Acquisitions
Genentech, Inc.: Partnership
Genentech, Inc.: Recent Developments
Genentech, Inc.: News and Events Summary
Genentech, Inc.: Business Expansion
Genentech, Inc.: Contracts
Genentech, Inc.: Financial Deals
Genentech, Inc.: Market Developments
Genentech, Inc.: Regulatory and Legal Events
Genentech, Inc.: Research & Development
Genentech, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Genentech, Inc.: Key Facts
Table 2: Genentech, Inc.: Key Employees
Table 3: Genentech, Inc.: Company History
Table 4: Genentech, Inc.: Locations and Subsidiaries
Table 5: Genentech, Inc.: Key Competitors
Table 6: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Genentech, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Genentech, Inc.: Targets and Partners
Table 9: Genentech, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Genentech, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 11: Genentech, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 12: Genentech, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 13: Genentech, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 14: Genentech, Inc.: News and Events Summary
Table 15: Genentech, Inc.: Business Expansion
Table 16: Genentech, Inc.: Contracts
Table 17: Genentech, Inc.: Financial Deals
Table 18: Genentech, Inc.: Market Developments
Table 19: Genentech, Inc.: Regulatory and Legal Events
Table 20: Genentech, Inc.: Research & Development
Table 21: Genentech, Inc.: Strategy and Operations
